Established in 2009, it is a company specialized in manufacturing and exporting pharmaceutical intermediates and UV Absorbents. It has 200 employees, with 31% of the total number of technical personnel with college degree or above. After years of hard work, Yongtong Co., Ltd. has achieved great leap forward development. It has two major production bases. Its headquarters is located in Ningdu, Jiangxi Province. It has a wholly-owned subsidiary Yongchun chemical new materials Co., Ltd. in Shaowu City, Fujian Province, which mainly produces p-cyanophenol and acetophenone series products. the company has established a sound corporate governance structure and scientific enterprise management system, and was successfully listed in the national small and medium-sized enterprise share transfer system (new third board) on December 23, 2014, with the stock code of 831705, referred to as Yongtong shares. The company has passed IS09001, ISO14001 and OHSAS18001 certification. the company has established a high-quality management and technical team, actively promoted the strategic cooperation with universities and scientific research institutes, and signed long-term industry university research cooperation agreements with Tianjin University School of chemical engineering, Jiangxi University of science and technology and other universities, expanding the talent introduction methods and technology sources of enterprises. Yongtong Co., Ltd. is mainly engaged in series products of p-tert-butylbenzoic acid, which is an important organic synthesis intermediate for the production of anti ultraviolet absorbent additives, polypropylene nucleating agent, heat stabilizer, etc. The company has built a series of p-tert-butylbenzoic acid production workshop with an annual output of 5000 tons. P-tert-butylbenzoic acid is recognized as "Jiangxi famous brand product". in order to accelerate the process of capital securitization and realize the transformation and upgrading of the company, we have planned the development goal and blueprint for the next five years: through five years of efforts, Jiangxi Yongtong Technology Co., Ltd. will become a world-class manufacturer of p-tert-butylbenzoic acid series products and biomedical products, and will land on the Shanghai and Shenzhen stock exchanges. To this end, the company has built an annual output of 10 tons of polymyxin B sulfate and 10 tons of bacitracin zinc API project. After the project was put into operation, nearly 100 people were employed.